Abstract

23
The generation of blood cellular components from hematopoietic stem cells is important for the 24 therapy of a broad spectrum of hematological disorders. In recent years, several lines of evidence 25 suggested that certain nutrients, vitamins and flavonoids may have important roles in controlling 26 the stem cell fate decision by maintaining their self-renewal or stimulating the lineage-specific 27 differentiation. In this study, main olive leaf phytochemicals, oleuropein (Olp), apigenin 7-28 glucoside (Api7G) and luteolin 7-glucoside (Lut7G) were investigated for their potential effects 29 on hematopoietic stem cell differentiation using both phenotypic and molecular analysis. 
Introduction
45
Hematopoiesis is a tightly regulated process maintained by a small pool of hematopoietic stem 46 cells (HSC) capable of undergoing self-renewal and generating mature progeny of all the 47
Differentiation marker expression
Phenotypic analysis of the expanded cells were carried out on the 3rd, 6th and 9th days by 135 analyzing the expression of surface markers such as CD34, CD38, CD33, CD10, CD14, CD41 136 and GlycophorinA (Abcam). The expanded control and treated cells were collected, the number 137 adjusted to 1 × 10 5 cells and washed with 1x PBS. After the addition of antibodies, the cells were 138 incubated for 40 min on ice. Excess antibody was removed by washing with 1x PBS before 139 analysis using Guava PCA. The expression level of each surface antigen in treated cells was 140 normalized to its expression level in control cells. 141
RNA isolation and real-time PCR analysis
142
Total RNA extraction of treated CD34+ cells, as well as control cells, was conducted on the 2nd, 143 5th and 8th day of culture using Isogen reagent (Nippon Gene Co., Ltd) following the 144 manufacturer's instructions. The isolated RNA was quantified using Nanodrop 2000 (Thermo 145 Scientific). First strand cDNA synthesis was carried out from about 1µg of total RNA using 146 Superscript III (Invitrogen) and oligo(dT) primers according to manufacturer's protocol. Real-147 time PCR was performed using TaqMan master mix and specific gene primers from Applied 148 Biosystems, specific for the 7500/7500 Fast RT-PCR system. Primers for α-hemoglobin, β-149 hemoglobin, γ-hemoglobin, GATA1, and the internal control β-actin , with the assay IDs listed in 150 Supplementary table (Table S1) , were all purchased from Applied Biosystems. 151
Microarray analysis
152
DNA microarray analysis was conducted on isolated RNA samples from cells treated with 153
Api7G for 2 days and 5 days. Double-stranded cDNA was synthesized from 100 ng of total RNA 154 using the GeneAtlas 3' IVT Express Kit (Affymetrix, Inc.). Biotin-labeled aRNA wassynthesized by in vitro transcription and purified. Purified aRNA (10 µg) was then fragmented 156 using the GeneAtlas 3' IVT Express Kit and was hybridized to the Affymetrix HG-U219 157 (Affymetrix) for 16h at 45ºC. The chips were washed and stained in the GeneAtlas Fluidics 158
Station 400 (Affymetrix) and then the resulting image scanned using the GeneAtlas Imaging 159 Station (Affymetrix). In order to identify the differentially expressed genes, data analysis was 160 conducted using Affymetrix® Expression Console™ Software and Affymetrix® Transcriptome 161 Analysis Console (TAC) 2.0 Software (Affymetrix). Gene ontology categories that are 162 statistically overrepresented were assessed using BiNGO 2.4 software (Biological Network Gene 163 Ontology) from Cytoscape (Maere et al., 2005) . The differentially expressed genes were also 164 subjected to hierarchical clustering using Euclidean distance and average linkage algorithm of 165 the TIGR Mev version 4.9 software (Saeed et al., 2003) . 166
Statistical analysis
167
Data are presented as the mean ± SD of three independent experiments. Statistical analyses were 168 performed based on a paired two-tailed student's t-test (Microsoft Excel). A p-value < 0.05 was 169 considered statistically significant. 170
Results
171
Major components of olive leaf and their combination were not 172 cytotoxic on CD34+ hematopoietic cells
173
The cell viability and the cell number of CD34+ hematopoietic stem/progenitor cells were 174 assessed every three days following treatment with the different samples. Results indicated that 175 the number of viable cells was decreased by Comb on the 3rd day of culture compared to control 176 cells, while no significant difference was observed on the 6th and 9th day of treatment. Thenumber of cells treated with Api7G was significantly lower than that of control cells throughout 178 the treatment periods while treatment with Lut7G had no effect on the cell number ( Figure 1A) . with Lut7G significantly increased the expression of GATA1 on the 5th day followed by an up-237 regulation of hemoglobin genes expressions on the 8th day. 238
Microarray analysis results
In order to get an insight into the mechanisms involved in the erythroid differentiation effect, 240 gene expression profiles in cells treated with Api7G were assessed after treatment for 2 days and 241 5 days. Only genes with more than 2-fold change (treatment/control) in expression were 242 considered for the analysis. and genes related to transcriptional activity such as the pre-mRNA processing factor 4B 252 (PRPF4B), the CDC like kinase 1 (CLK1) and the serine/arginine-rich splicing factors (SRSF1, 253 SRSF5, SRSF11). After treatment for 5 days, genes related to protein binding formed the major 254 category of the up-regulated genes. An up-regulation of genes of molecules functioning in 255 cytoskeletal organization such as the nucleolar and spindle associated protein 1 (NUSAP1), the 256 tropomyosin 1 (TPM1), the coronin actin binding protein 2A (CORO2A) and the subunit of actin 257 related protein complex (ARPC3), has been also observed in Api7G-treated cells. Hierarchical 258 clustering of the differentially expressed genes from 2 days and 5 days treatment with Api7G 259 generated two groups that represent the up-regulated genes on 2nd and 5th day, respectively 260 ( Figure 5) . Particularly, the level of expression of genes encoding for clatherin, heavy chain 261 (CLTC), the CCHC-type zinc finger nucleic acid binding protein (CNBP), the eukaryotictranslation initiation factor 4A2 (EIF4A2), the matrin 3 (MATR3) and the cathepsin C (CTSC), 263 was maintained for both 2 days and 5 days treatment ( Figure 5) . 264 A list of selected differentially expressed genes is presented in Table 2 . 265
Discussion
266
Olive leaf components used alone, or in combination, did not affect the cell viability of CD34+ 267 cells even though Comb-treatment and Api7G-treatment decreased the cell number, indicating a 268 slight inhibition in the growth rate (Figure 1 ). This decrease could be explained by the arrest of 269 the cell cycle at G0/G1 phase observed in the cells treated with Comb and Api7G (Table 1) . It is 270 a well-established fact that cell cycle arrest at G0/G1 phase is closely associated with 271 differentiation. Methods aimed at inhibiting the cell cycle at G0/G1 phase drive a rapid, 272 condensed differentiation to terminally differentiated cells, demonstrating that the cell cycle is a 273 principle rate-limiting step of differentiation throughout the early and late stages (Li and 274 Kirschner, 2014) . Accordingly, it is suggested that the G0/G1 arrest in CD34+ cells by Api7G or 275
Comb treatment enabled the cells to undergo the differentiation process. The molecular pathways 276 that couple cell cycle to differentiation involve molecules of the G1/S transition which includes 277 growth factors, downstream signaling pathways, Myc, the Rb/E2F pathway, and CDK inhibitors 278 (e.g. p21) (Li and Kirschner, 2014; Muñoz-Alonso and León, 2003) . Interestingly, microarray 279 analysis revealed an increase in the expression of genes that regulate the G1/S transition in 280
Api7G-treated cells after 2 days of treatment, particularly the cyclin-dependent kinase inhibitor 3 281 (CDKN3) whose encoded protein specifically dephosphorylate and inactivate CDK2, thereby 282 inhibiting G1/S cell cycle progression (Chen et al., 2014) . Phenotypic analysis of HSPCs treated with Lut7G revealed an increase in the GPA expression 319 after 9 days of incubation associated with a decrease of CD41 expression indicating a 320 commitment to the erythroid lineage and an inhibition of megakaryopoiesis. In addition, Lut7G 321 treatment significantly increased the expression of GATA1 mRNA on the 2nd day and the 5th 322 day of incubation followed by an increase in hemoglobin gene expression on the 8th day. A 323 slight increase in CD33 expression was also detected in Lut7G-treated cells for 9 days associated 324 with a significant reduction of CD14 expression suggesting that the increase in the 325 myelomonocytic population is due to the expansion of the granulocytic lineages rather than the 326 monocytic lineages. These results validate our previous report in which treatment with Lut7G 327 increased the number of colony-forming unit-granulocytes/macrophages and burst-forming unit-328 erythrocytes (Samet et al., 2014b) . In order to explore the mechanisms involved in the erythroid differentiation-inducing effect of 368 Api7G, microarray analysis was conducted on cells treated with Api7G for 2 days-and 5 days. 369
Interestingly, among the differentially expressed genes were those that have significant role in 370 erythroid differentiation, and the obtained results, therefore, are in correlation with the observed 371 effect. Api7G up-regulated the genes involved in heme biosynthesis such as the SLC25A37 gene 372 coding for the solute carrier family 25 member 37, a mitochondrial iron transporter that 373 specifically mediates iron uptake in developing erythroid cells, and the CPOX gene encoding the 374 coproporphyrinogen oxidase, a key enzyme in heme biosynthesis (Chen et al., 2009; Taketani et 375 al., 2001) . Moreover, GYPA and GYPB genes encoding the major sialoglycoproteins of the 376 human erythrocyte membrane were respectively up-regulated after treatment for 2 days and 5 377 days (Table 2) . 378
Results of the differentially increased genes indicated an up-regulation of janus kinase 2 (JAK2) 379 and signal transducer and activator of transcription 1 (STAT1) genes in Api7G-treated cells after 380 2 days of incubation (Table 2) Api7G-treated cells on the 5th day such as KPNA1, NMI, EP300 and CREBBP encoding 394 respectively for the nuclear protein importer NPI-1, the coactivator proteins N-myc-interactor 395
Nmi-1, the histone acetyltransferase p300 and the CREB binding protein CRB. Taken together 396 these findings indicate an activation of the JAK/STAT signaling pathway suggesting that this 397 pathway plays an important role in the initiation of erythroid differentiation by Api7G-treatment. apigenin 7-glucoside (Api7G) for 2 days and 5 days. Genes with more than 2-fold change were 587 subjected to hierarchical clustering. Horizontal stripes represent genes and columns show 588 experimental samples. Clustering was performed on genes using the Euclidian distance method. 589
Red and green color codes for up-and down-regulation, respectively. 
